Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. These compounds may help reduce symptoms and improve the quality of life for patients.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Dispensaries serve as the primary access point for patients seeking medical marijuana products. These cells can form tumours and interfere with normal body functions.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JUNE 28, 2021

The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. “We are constantly seeking ways to enhance the life of chronically neurologically ill patients with our products. The first treatment will be launched in Germany in Summer 2021.

Access 105

Access Research and Development Pharmaceutical Therapy 105

MMJ Recs

FEBRUARY 10, 2024

Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views. This change is driven by a combination of scientific research, increased education, and a desire for alternative healthcare options.

Research and Development 105

Research and Development Marijuana History Legislation 105

MMJ Recs

OCTOBER 26, 2023

This guide aims to provide an in-depth exploration of medical marijuana laws in the USA, offering insights into the regulations, the legal status of medical marijuana, the differences between federal and state laws, patient rights, dispensary regulations, and much more. Patients can possess up to one ounce of usable marijuana.

Law 98

Law Marijuana Programs Dispensary 98

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 105

Research and Development Conditions Data Patients 105

SpeedWeed

AUGUST 16, 2021

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ??5-MeO-DMT From Psychedelic Toad Venom to Medical Research.

Research and Development 52

Research and Development Clinical Trials Treatment Conditions 52

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

MMJ Recs

SEPTEMBER 19, 2023

Common Causes of Chronic Pain Chronic pain is a complex and often debilitating condition, and its underlying causes can vary widely. However, several common factors contribute to the development of chronic pain. Autoimmune diseases like fibromyalgia and conditions like migraines are also frequent contributors to chronic pain.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. Understanding these regulations is crucial for patients, caregivers, and dispensaries alike to ensure compliance with the law.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 98

Medicine Research and Development Safety THC 98

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Doctors will also be able to recommend medical pot to minors with ASD, but only if they can confirm that the patient has not responded to conventional medications or treatments.

Conditions 52

Conditions Programs Research and Development Marijuana 52

MMJ Recs

DECEMBER 19, 2022

Sometimes, in addition to MMJ treatment, patients need other methods to find some relief. How can I access California’s MMJ program? California has a well-developed MMJ program, with many dispensaries state-wide. Medical marijuana (MMJ) has been proven to help relieve chronic pain, but it’s not the only way. 17607277600.

Chronic Pain 52

Chronic Pain Patients Treatment Research and Development 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

MARCH 14, 2023

And the truth was that many of the early medical cannabis patients were severely ill. Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used.

Policy 96

Policy Research and Development Conditions Consumption 96

NORML

FEBRUARY 15, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? HI resident? KY resident?

Legislation 270

Legislation Decriminalization Access Patients 270

Cannabis Law Report

MAY 12, 2022

Beckley Psytech to collaborate with Lophora on researching New Clinical Entities (NCE’s). Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline and collaborate broadly on R&D. Beckley Psytech has been working diligently to build a first-class drug development capability.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. This exciting development could have profound implications for how we approach managing this type of pain. However, these approaches are not always practical for everyone. How Does Cannabis Spray Work?

Treatment 109

Treatment Therapy Research and Development THC 109

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients. This has led them to seek out alternative options like cannabis.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

JULY 19, 2021

Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction. We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

JUNE 8, 2021

OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

United Patients Group

JUNE 26, 2023

This expanding role has translated into an increased influence over the healthcare system, from hands-on patient care to high-level administrative decisions. Nurses play a critical part in shaping the health sector, leading efforts to improve patient care and outcomes. How Can Nurses Improve the Health Sector?

Research and Development 52

Research and Development Education Patients Policy 52

Veriheal

JUNE 20, 2023

In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine. Meanwhile, the research team remains committed to identifying even more accurate molecules for potential therapeutic applications.

Medicine 98

Medicine Research and Development Treatment Conditions 98

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98